Article
Fas cell surface death receptor/Fas ligand genetic variants in gastric cancer patients: A case-control study.
The Indian journal of medical research - 1 Jul 2022
Asgari Rezvan, Bidmeshkipour Ali, Mansouri Kamran, Bakhtiari Mitra, Mozafari Hadi, Abdolmaleki Amir
Abstract excerpt
Background & objectives: Various studies have suggested a correlation between Fas cell surface death receptor/Fas ligand (FAS/FASL) variants and multiple types of cancers. The present study aimed to investigate the association between FAS-670A/G and FASL-844C/T and the synergistic effects of both variants on the risk of gastric cancer (GC) in the Kurdish population of west of Iran. Methods: This study was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
